HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.

AbstractOBJECTIVE:
This study was undertaken to investigate whether recent advances in lupus nephritis treatment have led to changes in the incidence of end-stage renal disease (ESRD) secondary to lupus nephritis, or in the characteristics, treatments, and outcomes of patients with lupus nephritis ESRD.
METHODS:
Patients with incident lupus nephritis ESRD (1995-2006) were identified in the US Renal Data System. Trends in sociodemographic and clinical characteristics were assessed. We tested for temporal changes in standardized incidence rates (SIRs) for sociodemographic groups using Poisson regression. Changes in rates of waitlisting for kidney transplant, kidney transplantation, and all-cause mortality were examined using crude and adjusted time-to-event analyses.
RESULTS:
We identified 12,344 incident cases of lupus nephritis ESRD. Mean age at ESRD onset was 41 years; 81.6% of the patients were women and 49.5% were African American. SIRs for lupus nephritis ESRD among those who were ages 5-39 years, African American, or lived in the southeastern US increased significantly from 1995 to 2006. Increases in body mass index and in the prevalence of both diabetes mellitus and hypertension were detected. Mean serum hemoglobin level at ESRD onset increased, while that of serum creatinine decreased over time. More patients received hemodialysis and fewer received peritoneal dialysis. There was a slight increase in the frequency of preemptive kidney transplantation at ESRD onset, but kidney transplantation rates within the first 3 years of ESRD declined. Mortality did not change over the 12 years of study.
CONCLUSION:
Our findings indicate that the characteristics of patients with lupus nephritis ESRD and initial therapies have changed in recent years. While SIRs rose in younger patients, among African Americans, and in the South, outcomes did not improve in over a decade of evaluation.
AuthorsKaren H Costenbader, Amrita Desai, Graciela S Alarcón, Linda T Hiraki, Tamara Shaykevich, M Alan Brookhart, Elena Massarotti, Bing Lu, Daniel H Solomon, Wolfgang C Winkelmayer
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 63 Issue 6 Pg. 1681-8 (Jun 2011) ISSN: 1529-0131 [Electronic] United States
PMID21445962 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 by the American College of Rheumatology.
Topics
  • Adolescent
  • Adult
  • Black People (statistics & numerical data)
  • Body Mass Index
  • Child
  • Child, Preschool
  • Comorbidity
  • Diabetes Mellitus (epidemiology)
  • Female
  • Humans
  • Hypertension (epidemiology)
  • Incidence
  • Kidney Failure, Chronic (epidemiology, therapy)
  • Kidney Transplantation (statistics & numerical data)
  • Lupus Nephritis (epidemiology)
  • Male
  • Middle Aged
  • Prevalence
  • Renal Dialysis (statistics & numerical data)
  • Sex Factors
  • Treatment Outcome
  • United States (epidemiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: